Metabolomics biomarkers to predict acamprosate treatment response in alcohol-dependent subjects
Metabolomics biomarkers to predict acamprosate treatment response in alcohol-dependent subjects
About this item
Full title
Author / Creator
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Precision medicine for alcohol use disorder (AUD) allows optimal treatment of the right patient with the right drug at the right time. Here, we generated multivariable models incorporating clinical information and serum metabolite levels to predict acamprosate treatment response. The sample of 120 patients was randomly split into a training set (
Alternative Titles
Full title
Metabolomics biomarkers to predict acamprosate treatment response in alcohol-dependent subjects
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_d17a8ba0a08e49ca9953eacbb578a883
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d17a8ba0a08e49ca9953eacbb578a883
Other Identifiers
ISSN
2045-2322
E-ISSN
2045-2322
DOI
10.1038/s41598-017-02442-4
